The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 24, 2023

Filed:

Jun. 13, 2019
Applicant:

Astrazeneca Uk Limited;

Inventors:

Robert Peter Prybolsky, West Chester, PA (US);

Judy Firor, Landenberg, PA (US);

Assignee:

ASTRAZENECA UK LIMITED, Cambridge, GB;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/403 (2006.01); G16H 70/40 (2018.01); G16H 10/20 (2018.01); A61P 3/10 (2006.01); G06F 16/9038 (2019.01); G06F 16/9035 (2019.01); A61K 31/513 (2006.01); A61K 31/522 (2006.01); G06F 9/54 (2006.01);
U.S. Cl.
CPC ...
A61K 31/403 (2013.01); A61K 31/513 (2013.01); A61K 31/522 (2013.01); A61P 3/10 (2018.01); G06F 9/542 (2013.01); G06F 16/9035 (2019.01); G06F 16/9038 (2019.01); G16H 10/20 (2018.01); G16H 70/40 (2018.01);
Abstract

A method is provided for lowering blood sugar in a subject in need thereof by administering a dipeptidyl peptidase-4 inhibitor pharmaceutical composition to a subject qualified for over-the-counter access to the dipeptidyl peptidase-4 inhibitor pharmaceutical composition. In some embodiments, the dipeptidyl peptidase-4 inhibitor pharmaceutical composition includes saxagliptin, sitagliptin, linagliptin, alogliptin, or a pharmaceutically acceptable salt thereof. In some embodiments, the dipeptidyl peptidase-4 inhibitor pharmaceutical composition includes (1S,3S,5S)-2-[(2S)-2-amino-2-(3-hydroxy-1-adamantyl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile or a pharmaceutically acceptable salt thereof.


Find Patent Forward Citations

Loading…